Skip to main content
INO
NASDAQ Life Sciences

Inovio and Akeso Partner on Novel Glioblastoma Therapy, Dosing Expected H2 2026

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.75
Mkt Cap
$115.422M
52W Low
$1.3
52W High
$2.979
52W Position info
35% above low
Off High info
41% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

INO sits 35% above its 52-week low of $1.3.

Summary

Inovio Pharmaceuticals announced a clinical collaboration with Akeso to develop a novel combination therapy for Glioblastoma (GBM), a severe form of brain cancer. This partnership aims to advance a new treatment approach, with initial patient dosing anticipated in the second half of 2026. For Inovio, a small-cap biotech, this collaboration represents a significant expansion of its clinical pipeline and a strategic move into a high-unmet-need oncology area. The initiation of a new clinical trial, even in early stages, provides a potential long-term value driver. Investors will be watching for updates on trial enrollment and early safety/efficacy data.

At the time of this announcement, INO was trading at $1.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $115.4M. The 52-week trading range was $1.30 to $2.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INO - Latest Insights

INO
Nov 10, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.60 info
Change: +$0.135 (+9%) info
Market Cap: $298.754M info
INO
Nov 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.60 info
Change: +$0.125 (+9%) info
Market Cap: $298.754M info
INO
Nov 09, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $1.60 info
Change: +$0.225 (+16%) info
Market Cap: $298.754M info
INO
Nov 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.60 info
Change: +$0.385 (+32%) info
Market Cap: $298.754M info
INO
Nov 05, 2026, 11:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.60 info
Change: +$0.3656 (+30%) info
Market Cap: $298.754M info